This chemical is primarily utilized in the pharmaceutical industry as a key intermediate in the synthesis of various bioactive compounds. Its structure, featuring a piperazine ring and a benzylamine group, makes it valuable for developing molecules with potential therapeutic effects. It is often employed in the creation of drugs targeting the central nervous system, particularly in the development of antipsychotic and antidepressant medications. Additionally, its chemical framework is explored in the design of inhibitors for specific enzymes or receptors, contributing to advancements in medicinal chemistry. Its versatility also extends to research applications, where it serves as a building block for novel compounds in drug discovery programs.